These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease. Pastori D; Polimeni L; Baratta F; Pani A; Del Ben M; Angelico F Dig Liver Dis; 2015 Jan; 47(1):4-11. PubMed ID: 25224698 [TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of statin therapy. Adhyaru BB; Jacobson TA Nat Rev Cardiol; 2018 Dec; 15(12):757-769. PubMed ID: 30375494 [TBL] [Abstract][Full Text] [Related]
16. Statin use in patients with elevated serum hepatic transaminases at baseline: A meta-analysis. Masson W; Lobo M; Masson G; Molinero G; Casciato P Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1357-1364. PubMed ID: 33715945 [TBL] [Abstract][Full Text] [Related]
17. Nonadherence to statins: individualized intervention strategies outside the pill box. Lansberg P; Lee A; Lee ZV; Subramaniam K; Setia S Vasc Health Risk Manag; 2018; 14():91-102. PubMed ID: 29872306 [TBL] [Abstract][Full Text] [Related]
18. Prescription of statins to dyslipidemic patients affected by liver diseases: a subtle balance between risks and benefits. Anfossi G; Massucco P; Bonomo K; Trovati M Nutr Metab Cardiovasc Dis; 2004 Aug; 14(4):215-24. PubMed ID: 15553600 [TBL] [Abstract][Full Text] [Related]
19. The role of fenofibrate in clinical practice. Zambon A; Cusi K Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S15-20. PubMed ID: 17935056 [TBL] [Abstract][Full Text] [Related]
20. The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges. Ahmed MH; Al-Atta A; Hamad MA Expert Opin Pharmacother; 2012 Sep; 13(13):1901-9. PubMed ID: 22770622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]